エピソード

  • From Innovation to Implementation: AI in Action

    From Innovation to Implementation: AI in Action
    2026/01/28
    Guests Michael Pencina and Suresh Balu join the Beyond the Endpoint hosts to explore the impact of AI in healthcare. They discuss the role of AI-powered tools in research, clinical care, and operations, while examining evidence standards, transparency challenges, and the potential evolution of the physician-patient relationship. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-10-innovation-implementation-ai-action
    続きを読む 一部表示
    26 分
  • Beyond the Headlines Series: Looking back at 2025 headlines, Dementia & Vaccines, and Cannabis Research

    Beyond the Headlines Series: Looking back at 2025 headlines, Dementia & Vaccines, and Cannabis Research
    2026/01/14
    Kick off 2026 with hosts Manesh Patel and Emily O'Brien as they evaluate last year's most discussed health stories and wellness trends, cannabis reclassification, and a shingles vaccine-dementia study. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-9-beyond-headlines
    続きを読む 一部表示
    21 分
  • Behind the Voices: Get to Know Emily & Manesh

    Behind the Voices: Get to Know Emily & Manesh
    2025/12/17
    Hosts Manesh Patel and Emily O'Brien share their amusing and inspiring personal and professional trajectories, exploring how mentors shaped their paths in clinical research, why asking unconventional questions matters, and how success rarely follows a straight line. 🎙️ Listen now for the full conversation: https://dcri.org/blog/s2-ep-8-behind-voices-get-know-emily-manesh
    続きを読む 一部表示
    28 分
  • From Provider to Patient: A Dual Perspective on Colorectal Cancer

    From Provider to Patient: A Dual Perspective on Colorectal Cancer
    2025/12/03
    Hosts Emily O’Brien and Manesh Patel sit down with Dr. Ajay Kohli and Dr. Julius Wilder for a dual-perspective conversation on colorectal cancer, where they discuss personal experiences, the importance of early detection, screening disparities, and how equitable access to care saves lives. 🔗Access resources related to this episode: https://dcri.org/blog/s2-ep-7-provider-patient-dual-perspective-colorectal-cancer
    続きを読む 一部表示
    39 分
  • Beyond the Headlines: Recap of the 2025 AHA Scientific Sessions

    Beyond the Headlines: Recap of the 2025 AHA Scientific Sessions
    2025/11/19
    Recorded at the 2025 American Heart Association Scientific Sessions, hosts Manesh Patel and Emily O'Brien discuss late-breaking cardiovascular research, including gene-editing therapy for cholesterol, AFib management strategies, and, for coffee lovers, the DECAF trial's findings on caffeine and heart rhythm. #AHA25 #beyondtheendpoint #cardiology #podcast #hearthealth #clinicalresearch
    続きを読む 一部表示
    21 分
  • Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next

    Connecting the Dots: The Broader Applications of GLP-1s and Where We’re Headed Next
    2025/11/04
    Endocrinologist Jennifer Green discusses how GLP-1 drugs, like Ozempic, evolved from diabetes tools to potential treatments for addiction and heart disease, in this final installment of the obesity series. The discussion also touches on critical questions about long-term use, access, and emerging innovations. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-5-connecting-dots-broader-applications-glp-1s-and-where-were-headed-next
    続きを読む 一部表示
    37 分
  • Obesity, GLP-1s, and the Evidence: What the Data Tells Us

    Obesity, GLP-1s, and the Evidence: What the Data Tells Us
    2025/10/22
    In this second episode of our obesity series, preventive cardiologist Neha Pagidipati sheds light on the discovery, impact, and uses of GLP-1s, like Ozempic and Mounjaro. Learn about the impact these medications are having on diabetes, heart disease, and weight management. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-4-obesity-glp-1s-and-evidence-what-data-tells-us
    続きを読む 一部表示
    31 分
  • It's Not Just the Scale: Supporting Sustainable Change in Obesity Treatment

    It's Not Just the Scale: Supporting Sustainable Change in Obesity Treatment
    2025/10/08
    In the first of a three-part series on obesity and GLP-1 medications, our guest Jennifer Norris shares the evolving landscape of obesity treatment. The conversation addresses common misconceptions and examines how GLP-1 medications, such as Ozempic, have transformed care alongside surgery and lifestyle interventions.
    続きを読む 一部表示
    32 分